سعر السهم
30.00
التغيير اليومي
-0.83 -2.69%
شهريا
41.58%
سنويا
41.84%
Q1 التوقعات
32.30




رأس المال والاحتياطيات تغيير تاريخ
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.25B 984.93M 2025-06
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Gilead Sciences USD 22.62B 1.16B 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
MacroGenics USD 55.59M 11.41M 2025-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 8.67M 4.76M 2022-06
Pfizer USD 92.8B 4.11B 2025-09
Pharma Mar EUR 251.83M 54.32M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Takeda JPY 7.64T 513.39B 2025-12
Tilray USD 1.58B 39.08M 2025-09
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09